Actively Recruiting

Age: 18Years +
All Genders
NCT06089031

Belgian Registry on Coronary Function Testing

Led by University Hospital, Antwerp · Updated on 2023-10-18

650

Participants Needed

13

Research Sites

271 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this prospective, multicenter registy is to describe the 'real-world' use of coronary function tests, which may consist of bolus thermodilution measurements of coronary microvascular function and/or invasive vasoreactivity tests with acetylcholine, in the current Belgian routine practice. The main questions it aims to answer are: * how frequent are coronary function tests performed * what is the indication for coronary function tests * what is the frequency of coronary microvascular dysfunction * what is the frequency of coronary artery vasospasm From each participant, data will be collected from their medical files concerning cardiovascular risk factors, relevant past medical history, non-invasive tests, procedural data, and follow-up data from routine in-patient visits. Their are no specific study visits. Optionally, patients will be asked to fill in questionnaires about anginal symptoms and quality of life.

CONDITIONS

Official Title

Belgian Registry on Coronary Function Testing

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient scheduled for coronary function test, comprising of intracoronary bolus thermodilution measurements of microvascular function, and/or intracoronary vasoreactivity tests with acetylcholine.
  • Subject understands the study requirements and provides written informed consent.
Not Eligible

You will not qualify if you...

  • Subject is participating in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
  • Subject intends to participate in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
  • Documented or suspected pregnancy.
  • Inability to provide written informed consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 13 locations

1

AZ Monica

Deurne, Antwerp, Belgium, 2100

Actively Recruiting

2

AZ Sint-Maarten

Mechelen, Antwerp, Belgium, 2800

Actively Recruiting

3

Jessa Hasselt

Hasselt, Limburg, Belgium, 3500

Actively Recruiting

4

OLV Aalst

Aalst, Belgium, 9300

Actively Recruiting

5

Ziekenhuis aan de Stroom (ZAS)

Antwerp, Belgium, 2020

Actively Recruiting

6

University Hospital Antwerp

Antwerp, Belgium, 2650

Actively Recruiting

7

AZ Sint-Jan Brugge

Bruges, Belgium, 8000

Actively Recruiting

8

AZ Jan Yperman

Ieper, Belgium, 8900

Actively Recruiting

9

AZ Groeninge

Kortrijk, Belgium, 8500

Actively Recruiting

10

UZ Leuven

Leuven, Belgium, 3000

Actively Recruiting

11

CHC Montlégia Liège

Liège, Belgium, 4000

Actively Recruiting

12

CHR Citadelle Liège

Liège, Belgium

Actively Recruiting

13

AZ Delta

Roeselare, Belgium, 8800

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here